FTC Claims Success as Ohio Hospital Alters Merger Plan
The Federal Trade Commission announced a win after challenging Fairfield Medical Center's proposed merger with OhioHealth. The hospital instead agreed to partner with Adena Health, a smaller system. The revised deal addresses antitrust concerns.
The Federal Trade Commission said its antitrust review prompted Fairfield Medical Center to abandon its planned merger with OhioHealth, a larger regional system. Instead, the hospital will partner with Adena Health, a smaller competitor, a structure the FTC believes preserves market competition. The regulator framed the outcome as a victory for its enforcement efforts.
The case reflects ongoing federal scrutiny of hospital consolidation, which regulators argue can drive up prices and reduce access to care. OhioHealth and Adena are both established systems in the state, but their differing sizes and service footprints likely factored into the FTC's assessment of competitive impact. The revised arrangement allows Fairfield to pursue operational benefits without eliminating a rival.
This decision could signal continued federal resistance to hospital consolidation, particularly in markets where a merger would significantly reduce patient choice. Communities served by Fairfield may see fewer immediate changes than originally proposed, though long-term effects on pricing and service availability remain uncertain. Patients and employers in the region could benefit from preserved competition, while smaller systems like Adena may gain leverage in negotiating with larger insurers and suppliers.